ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,024
Screening encounters
3,451
Diagnostic referrals
654
Outstanding pathways
243

Screening pathway

  1. Screening3,451Encounters
  2. Positive finding1,182Documented findings
  3. Referral654Diagnostic referrals
  4. Follow-up770Diagnostic visits
  5. Outcome411Resolved pathways

Stage totals use different units. Pending pathways: 243. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0761 · EXP-0761Synthetic · Site B

Full participant history through 2026-06-25, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-24

Referral-time risk

No matching referral was available at this observation date.

Screened participants

3024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3269 · Expanded synthetic participant 3269Site B — Peri-Urban Access Programme
EXP-3270 · Expanded synthetic participant 3270Site A — Urban Referral Hub
EXP-3271 · Expanded synthetic participant 3271Site B — Peri-Urban Access Programme
EXP-3274 · Expanded synthetic participant 3274Site D — Community Engagement Programme
EXP-3277 · Expanded synthetic participant 3277Site D — Community Engagement Programme
EXP-3281 · Expanded synthetic participant 3281Site B — Peri-Urban Access Programme
EXP-3284 · Expanded synthetic participant 3284Site C — Rural Outreach Programme
EXP-3286 · Expanded synthetic participant 3286Site A — Urban Referral Hub
EXP-3288 · Expanded synthetic participant 3288Site B — Peri-Urban Access Programme
EXP-3293 · Expanded synthetic participant 3293Site C — Rural Outreach Programme
EXP-3295 · Expanded synthetic participant 3295Site B — Peri-Urban Access Programme
EXP-3297 · Expanded synthetic participant 3297Site A — Urban Referral Hub
EXP-3300 · Expanded synthetic participant 3300Site C — Rural Outreach Programme
EXP-3301 · Expanded synthetic participant 3301Site A — Urban Referral Hub
EXP-3302 · Expanded synthetic participant 3302Site E — Resource-Constrained Navigation Programme
EXP-3303 · Expanded synthetic participant 3303Site D — Community Engagement Programme
EXP-3304 · Expanded synthetic participant 3304Site A — Urban Referral Hub
EXP-3306 · Expanded synthetic participant 3306Site B — Peri-Urban Access Programme
EXP-3308 · Expanded synthetic participant 3308Site D — Community Engagement Programme
EXP-3309 · Expanded synthetic participant 3309Site B — Peri-Urban Access Programme
EXP-3310 · Expanded synthetic participant 3310Site C — Rural Outreach Programme
EXP-3311 · Expanded synthetic participant 3311Site A — Urban Referral Hub
EXP-3312 · Expanded synthetic participant 3312Site D — Community Engagement Programme
EXP-3313 · Expanded synthetic participant 3313Site C — Rural Outreach Programme
EXP-3317 · Expanded synthetic participant 3317Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1384
HPV DNA
1565
Cytology
502

Navigation activity

Barrier documented
558
Contact attempt
964
Navigation intervention
241
Diagnostic booking
812
Diagnostic visit
770

Documented barriers

Contact difficulty
182
Transport difficulty
174
Appointment coordination
202

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.